A role for HLA‐DO as a co‐chaperone of HLA‐DM in peptide loading of MHC class II molecules

In B cells, the non‐classical human leukocyte antigens HLA‐DO (DO) and HLA‐DM (DM) are residents of lysosome‐like organelles where they form tight complexes. DM catalyzes the removal of invariant chain‐derived CLIP peptides from classical major histocompatibility complex (MHC) class II molecules, chaperones them until peptides are available for loading, and functions as a peptide editor. Here we show that DO preferentially promotes loading of MHC class II molecules that are dependent on the chaperone activity of DM, and influences editing in a positive way for some peptides and negatively for others. In acidic compartments, DO is engaged in DR–DM–DO complexes whose physiological relevance is indicated by the observation that at lysosomal pH DM–DO stabilizes empty class II molecules more efficiently than DM alone. Moreover, expression of DO in a melanoma cell line favors loading of high‐stability peptides. Thus, DO appears to act as a co‐chaperone of DM, thereby controlling the quality of antigenic peptides to be presented on the cell surface.

[1]  P. A. Peterson,et al.  Altered antigen presentation in mice lacking H2-O. , 1998, Immunity.

[2]  A. Rudensky,et al.  Invariant Chain–independent Function of H-2M in the Formation of Endogenous Peptide–Major Histocompatibility Complex Class II Complexes In Vivo , 1998, The Journal of experimental medicine.

[3]  Kevin E. Swier,et al.  A critical, invariant chain-independent role for H2-M in antigen presentation. , 1998, Journal of immunology.

[4]  L. Van Kaer,et al.  MHC class II expression in double mutant mice lacking invariant chain and DM functions. , 1998, Journal of immunology.

[5]  J. Trowsdale,et al.  HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.

[6]  P. Cresswell,et al.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.

[7]  C. Benoist,et al.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Douek,et al.  HLA-DO is an intracellular class II molecule with distinctive thymic expression. , 1997, International immunology.

[9]  G. Hämmerling,et al.  HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. , 1997, Immunity.

[10]  J. Frydman,et al.  Chaperones get in touch: the Hip-Hop connection. , 1997, Trends in biochemical sciences.

[11]  G. Hämmerling,et al.  How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.

[12]  B. Carreno,et al.  Are transporter associated with antigen processing (TAP) and tapasin class I MHC chaperones? , 1997, Journal of immunology.

[13]  S. Pierce,et al.  HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. , 1996, Journal of immunology.

[14]  P. Cresswell,et al.  HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.

[15]  G. Hämmerling,et al.  Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.

[16]  J. Trowsdale,et al.  Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs , 1996, The Journal of experimental medicine.

[17]  A. Sant,et al.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.

[18]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[19]  G. Hämmerling,et al.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Jackson,et al.  HLA‐DO is a lysosomal resident which requires association with HLA‐DM for efficient intracellular transport. , 1996, The EMBO journal.

[21]  P. Cresswell,et al.  HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. , 1996, Immunity.

[22]  P. A. Peterson,et al.  Antigen Presentation and T Cell Development in H2-M-Deficient Mice , 1996, Science.

[23]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[24]  C. Benoist,et al.  Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.

[25]  G. Hämmerling,et al.  Self-Release of CLIP in Peptide Loading of HLA-DR Molecules , 1995, Science.

[26]  B. Dobberstein,et al.  Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. , 1995, Journal of immunology.

[27]  P. A. Peterson,et al.  The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. , 1995, Immunity.

[28]  J. Bonifacino,et al.  A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments , 1995, The Journal of cell biology.

[29]  K. Mason,et al.  Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. , 1995, International immunology.

[30]  G. Hämmerling,et al.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[32]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[33]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[34]  P. Cresswell,et al.  Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles , 1995, The Journal of experimental medicine.

[35]  A Sette,et al.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.

[36]  J. Trowsdale,et al.  Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. , 1994, Science.

[37]  P. Cresswell,et al.  In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. , 1994, Immunity.

[38]  P. Cresswell,et al.  Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. , 1994, Immunity.

[39]  J. Strominger,et al.  Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH , 1994, The Journal of experimental medicine.

[40]  H. Ploegh,et al.  Mapping functional regions in the lumenal domain of the class II- associated invariant chain , 1994, The Journal of experimental medicine.

[41]  Jeffrey A. Shaman,et al.  An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.

[42]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[43]  M. Taylor,et al.  Endosomal aspartic proteinases are required for invariant-chain processing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Carcelain,et al.  Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. , 1993, Cancer research.

[45]  R. Germain,et al.  Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules , 1993, Nature.

[46]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[47]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[48]  H. Kalbacher,et al.  Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. , 1991, Biochemistry.

[49]  R. Germain,et al.  A role for peptide in determining MHC class II structure , 1991, Nature.

[50]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[51]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[52]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[53]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[54]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[55]  B. Arp,et al.  Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes , 1990, Nature.

[56]  K. Arai,et al.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat , 1988, Molecular and cellular biology.

[57]  P. A. Peterson,et al.  Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family. , 1987, The Journal of biological chemistry.

[58]  Eric O Long,et al.  DO beta: a new beta chain gene in HLA‐D with a distinct regulation of expression. , 1985, The EMBO journal.

[59]  J. Trowsdale,et al.  The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. , 1985, The EMBO journal.

[60]  J. Bodmer,et al.  Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. , 1983, Immunology.

[61]  L. Lampson,et al.  Two populations of Ia-like molecules on a human B cell line. , 1980, Journal of immunology.

[62]  R. Zahler Enzyme Structure and Mechanism , 1979, The Yale Journal of Biology and Medicine.

[63]  J. Trowsdale,et al.  Association between HLA-DM and HLA-DR in vivo. , 1996, Immunity.

[64]  D. O'reilly,et al.  Baculovirus expression vectors: a laboratory manual. , 1992 .

[65]  M. Ashburner A Laboratory manual , 1989 .